October was a month about the gap between owning a right and controlling an outcome. A valid patent on a drug’s mechanism that left its owner with no market. A licence...
Many companies treat IP ownership as something settled after a contract is won. However, a buyer large enough to set the terms can make ownership a condition of bidding. When that...
If AI collapses the cost of making your product, the question is no longer how cheaply you can make it. It is what stops a competitor making the same thing. That...
Capability is not what separates an attacker from a defender. Incentives are. Ben Thompson’s Stratechery piece of 24 August 2026 works this through in agentic cybersecurity, and the logic travels a...
Most boards plan around a single date. The patent expires, competitors arrive, the revenue line falls off a ledge. That model is tidy, it sits in the forecast, and for high-value...
When a market is about to triple in a decade, the patent filing map you drew for yesterday’s demand is the one that will let you down. A McKinsey analysis, written...
The most expensive failures in R&D are not the projects that fail. They are the projects that should never have started — and the ones that limp along because nobody had...
July was a month about ownership. Not compliance, not litigation skill – ownership. Google’s edge sits on TPU technology that competitors must come back and license. Sanofi lost the mRNA product...
When Berkshire Hathaway takes a $10 billion stake in Alphabet, the headline is the money. The real story is what Google chose not to monetise on its own. Google’s most valuable...
What happens when intellectual property built into your products turns out to belong to someone else? This week supplied three expensive answers. Each involved one of the world’s most powerful companies...
You must be logged in to post a comment.